Nuria C. Silva-Luna

Hospital De La Niñez Oaxaqueña 'Dr. Guillermo Zárate Mijangos'
Oaxaca, OAX, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Prevalence of TPMT and NUDT15 diplotypes in Mexican children with B-cell acute lymphoblastic leukemia.

Prevalence of TPMT and NUDT15 diplotypes in Mexican children with B-cell acute lymphoblastic leukemia.

Journal: Pharmacogenetics and genomics

Published: February 03, 2026

Geographic and Socioeconomic Determinants of Treatment Abandonment in Pediatric Acute Leukemia: A Cohort Study in South-Central Mexico.

Geographic and Socioeconomic Determinants of Treatment Abandonment in Pediatric Acute Leukemia: A Cohort Study in South-Central Mexico.

Journal: Cancer control : journal of the Moffitt Cancer Center

Published: January 16, 2026

Impact of standardized immunophenotyping and MRD monitoring on early mortality reduction in childhood leukemia: a step towards addressing healthcare disparities in vulnerable populations from Southern Mexico.

Impact of standardized immunophenotyping and MRD monitoring on early mortality reduction in childhood leukemia: a step towards addressing healthcare disparities in vulnerable populations from Southern Mexico.

Journal: Frontiers in oncology

Published: April 18, 2025

IKZF1plus is a frequent biomarker of adverse prognosis in Mexican pediatric patients with B-acute lymphoblastic leukemia.

IKZF1plus is a frequent biomarker of adverse prognosis in Mexican pediatric patients with B-acute lymphoblastic leukemia.

Journal: Frontiers in oncology

Published: November 13, 2023

Subclassification of B-acute lymphoblastic leukemia according to age, immunophenotype and microenvironment, predicts MRD risk in Mexican children from vulnerable regions.

Subclassification of B-acute lymphoblastic leukemia according to age, immunophenotype and microenvironment, predicts MRD risk in Mexican children from vulnerable regions.

Journal: Frontiers in oncology

Published: September 29, 2023

Implementation of a roadmap for the comprehensive diagnosis, follow-up, and research of childhood leukemias in vulnerable regions of Mexico: results from the PRONAII Strategy.

Implementation of a roadmap for the comprehensive diagnosis, follow-up, and research of childhood leukemias in vulnerable regions of Mexico: results from the PRONAII Strategy.

Journal: Frontiers in oncology

Published: September 29, 2023

Epidemiology of childhood acute leukemias in marginalized populations of the central-south region of Mexico: results from a population-based registry.

Epidemiology of childhood acute leukemias in marginalized populations of the central-south region of Mexico: results from a population-based registry.

Journal: Frontiers in oncology

Published: September 29, 2023

Molecular and cellular markers for measurable residual disease in acute lymphoblastic leukemia.

Molecular and cellular markers for measurable residual disease in acute lymphoblastic leukemia.

Journal: Boletin medico del Hospital Infantil de Mexico

Published: June 24, 2021

Poor Prognosis Biomolecular Factors Are Highly Frequent in Childhood Acute Leukemias From Oaxaca, Mexico.

Poor Prognosis Biomolecular Factors Are Highly Frequent in Childhood Acute Leukemias From Oaxaca, Mexico.

Journal: Technology in cancer research & treatment

Published: July 02, 2020

Prevalence of inhibitors and clinical characteristics in patients with haemophilia in a middle-income Latin American country.

Prevalence of inhibitors and clinical characteristics in patients with haemophilia in a middle-income Latin American country.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: October 09, 2019

Showing 1-10 of 10

Last Updated: 09/26/2026